Movement Disorders  >>  ropinirole IR  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ropinirole IR / Generic mfg.
NCT00422994: A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

Completed
1
48
US, Europe
ropinirole dosing for up to 28 days
GlaxoSmithKline
Restless Legs Syndrome
12/06
12/06
NCT00419692 / 2006-002139-26: Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Completed
1
32
Europe, RoW
Ropinirole
GlaxoSmithKline
Restless Legs Syndrome
12/06
12/06
NCT00140712: Ropinirole Tablets In Young Patients With Restless Legs Syndrome

Completed
1
9
US, Europe
Ropinirole Immediate Release
GlaxoSmithKline
Restless Legs Syndrome
02/08
02/08
NCT01371682: A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Completed
1
50
Europe
Ropinirole XL
GlaxoSmithKline
Parkinson Disease
12/09
12/09
NCT01435915: Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Completed
1
24
RoW
Ropinirole
GlaxoSmithKline
Parkinson Disease
08/10
08/10

Download Options